Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended Jun... (

Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008

Date:8/6/2008

- Mylan Increases Adjusted EPS Guidance for 2008 to $0.47

- $0.53

PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced its financial results for the three and six months ended June 30, 2008.

Financial Highlights

-- Adjusted diluted EPS of $0.16 for the three months ended June 30, 2008, which excludes the impact of certain purchase accounting items as well as other non-recurring items as discussed in detail below;

-- Total revenues of $1.20 billion for the three months ended June 30, 2008, an increase of $656.8 million over the same prior year period; and

-- On a GAAP basis, primarily as a result of purchase accounting items, the Company reported a loss per diluted share of $0.03 for the three months ended June 30, 2008.

"Our strong second quarter results were driven by a solid performance by each of our operating units and reflect the value we anticipated when we created our global platform," said Mylan Vice Chairman and CEO Robert J. Coury. "Based on the strength of our operations, our integration successes and the momentum of three consecutive quarters of strong results, we have increased the range of our earnings guidance."

Detailed Financial Summary

Mylan previously had two reportable segments, the Mylan Segment and the Matrix Segment. With the acquisition of Merck Generics on October 2, 2007, Mylan now has three reportable segments: Generics Segment (or Generics), Specialty Segment (or Specialty) and the Matrix Segment (or Matrix). The former Mylan Segment is included within the Generics Segment. Additionally, certain general and administrative and research and development expenses not allocated to the segmen
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.

Post Your Comments:

(Date:3/11/2010)... ... , ... ... ... health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women ...

(Date:3/11/2010)... ... , ... ... ... today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead to two to three women dying daily in ...

(Date:3/11/2010)... ... , , ... ... ... a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care that the government is ignoring lead ...

(Date:3/11/2010)... Farmington Hills, Mich. , physician ... Detroit federal jury on all 13 charged counts ... million Medicare fraud scheme, announced Assistant Attorney General ... Attorney for the Eastern District of Michigan Barbara L. ... the FBI,s Detroit Field Office; and Special Agent in ...

(Date:3/11/2010)... call for specific treatments, experts say , , THURSDAY, ... wisdom about blood pressure and stroke, new British ... not just high blood pressure, can greatly increase ... have very stable hypertension, in which case simple ... episodic hypertension is very common and matters much ...

[0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; North Carolina is 37th Among All States in Maternal Mortality [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Delaware is 42nd Among All States in Maternal Mortality [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Louisiana is 46th Among All States in Maternal Mortality [1] Detroit-Area Doctor Convicted in Medicare Fraud Scheme [0] Variable Blood Pressure a New Stroke Risk Factor?

... Scientific and Industrial Research Organization (CSIRO) may increase ... Stanton, Nutritionist. //Dr. Stanton has asked the Australian ... involved in recommending CSIRO diet as it contains ... to recommend the Australian Governments Australian Guide to ...

... if fish oil supplements, namely omega-3, will help special children ... a fatty acid EPA which serves to help the brain ... been proved that it can contribute towards improving concentration, memory, ... conducted on 38 students for a period of six months ...

... Bower, Ph.D. of the University of California at Los Angeles ... breast cancer survivors. // ,The study interviewed 763 women ... to fill in questionnaires. The study revealed shocking results that ... ten years after surgery and diagnosis. ,This condition ...

... is well-established fact that the incidence of breast cancer ... individual. This observation also holds good in the treatment ... that decisions regarding treatment are largely dependent on the ... the observation of significant racial differences in the management ...

... people-three in Ankara and two in Van-have tested positive for the ... said on Sunday. They are on treatment.// ,Turan Buzgan, ... that so far 28 people were tested at a government laboratory ... of people infected with H5N1, the most virulent form of the ...

... recent research has confirmed that lonely elderly people seek the company ... 37 elderly people were surveyed // in the survey, and most ... a part of the study, half of the senior citizens spent ... with one to three other nursing home residents and a dog. ...

Other Medicine News:Health News:Breast Cancer Treatment Influenced By Family 2

Controversy over Healthy diet may lead to less red meat in diet Omega-3 May Help Special Children Fatigue, Prevalent Among Patients Treated For Breast Cancer Breast Cancer Treatment Influenced By Family Five in Turkey infected with H5N1 virus: health official Elderly People Prefer The Company Of Pet Dogs

(Date:3/11/2010)... Feb. 25 Dr. Robert ... entitled "Touch Surfaces: The Silent Threat," ... warns that in the current worldwide H1N1 pandemic, ... of bacterial and viral infections. Dr. Arnot, a ... Educator of www.touchsurfaces.org , also offers infection-prevention ...

(Date:3/11/2010)... PCB and high quality OEM/ODM products today announced successful certification to the ISO 13485: 2003 Quality Management Standard (QMS) for Medical Devices. , ... ... ... ... The ISO ...

(Date:3/11/2010)... BEDFORD, Mass. , March 11 VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today ... range of in vitro and in vivo imaging applications. , ... , ... ... ...

Breaking Medicine Technology:Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 2 Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases 3 Lorom West Announces Successful Certification to the ISO 13485: 2003 Quality Management Standard (QMS) for Medical Devices 2 Lorom West Announces Successful Certification to the ISO 13485: 2003 Quality Management Standard (QMS) for Medical Devices 3 VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 2 VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 3 VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 4 3SBio Inc Applies for SFDA Registrational Trial for Feraheme 28TM 29 15278 1 3SBio Inc Applies for SFDA Registrational Trial for Feraheme 28TM 29 15278 2 3SBio Inc Applies for SFDA Registrational Trial for Feraheme 28TM 29 15278 3 3SBio Inc Applies for SFDA Registrational Trial for Feraheme 28TM 29 15278 4 China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base 15275 1 China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base 15275 2 China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base 15275 3 Study Shows Bacterial Contamination Associated With Home Laundered Surgical Scrubs Is Significantly Greater Than Other Options 7267 1 Study Shows Bacterial Contamination Associated With Home Laundered Surgical Scrubs Is Significantly Greater Than Other Options 7267 2

[0] Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases [0] Lorom West Announces Successful Certification to the ISO 13485: 2003 Quality Management Standard (QMS) for Medical Devices [0] VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label

... 24 Morria Biopharmaceuticals Plc, a,biopharmaceutical company focused ... that it has initiated a Phase II,equivalent study ... 105 patients,suffering from allergic rhinitis (AR). The two-arm, ... steroid,comparator arm. The study is expected to be ...

... to be held today at 10 a.m. EDT, ... /PRNewswire-FirstCall/,-- Genzyme Corp. (Nasdaq: GENZ ) and ... of the license and collaboration,agreement for mipomersen. The ... a novel lipid-lowering drug discovered and,developed by Isis ...

Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis Genzyme and Isis Complete Licensing of Mipomersen

Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....

... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...

... Freedom leg bags are part of ... versatile line of leg bags, kits, ... varied needs of our customers. These ... sizes, and constructed of 100% latex-free ...

... on delicate urethral tissues. The ... coating provide nearly friction-free movement, ... easy to maintain sterility. You ... its own sterile water, avoiding ...

Medicine Products:

Alpine Reusable Leg Bag - 32 oz. Capacity Freedom® Twist Drainage Port Leg Bags Freedom® Comfort Strap T-Tap Leg Bag Kits Hydrophilic Personal Catheter-Female

Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended Jun...( - Mylan Increases Adjusted E...),Health